339 related articles for article (PubMed ID: 22695057)
1. [Intravitreal injection of bevacizumab for CNV secondary to choroidal osteoma and follow-up by Spectral-Domain OCT].
Mercé E; Korobelnik JF; Delyfer MN; Rougier MB
J Fr Ophtalmol; 2012 Sep; 35(7):508-13. PubMed ID: 22695057
[TBL] [Abstract][Full Text] [Related]
2. Dramatic response of choroidal neovascularization associated with choroidal osteoma to the intravitreal injection of bevacizumab (Avastin).
Ahmadieh H; Vafi N
Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1731-3. PubMed ID: 17653753
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of changes in choroidal neovascularization secondary to age-related macular degeneration after anti-VEGF therapy using spectral domain optical coherence tomography.
You JY; Chung H; Kim HC
Curr Eye Res; 2012 May; 37(5):438-45. PubMed ID: 22510011
[TBL] [Abstract][Full Text] [Related]
4. Retinal pigment epithelium tear formation following intravitreal ranibizumab injection in choroidal neovascularization secondary to choroidal osteoma.
Erol MK; Coban DT; Ceran BB; Bulut M
Cutan Ocul Toxicol; 2014 Sep; 33(3):259-63. PubMed ID: 24517498
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal bevacizumab in the management of subretinal fluid associated with choroidal osteoma.
Song JH; Bae JH; Rho MI; Lee SC
Retina; 2010 Jun; 30(6):945-51. PubMed ID: 20531145
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal bevacizumab for choroidal neovascularization associated with choroidal nevus.
Chiang A; Bianciotto C; Maguire JI; Park CH; Baker PS; Shields JA; Shields CL
Retina; 2012 Jan; 32(1):60-7. PubMed ID: 21886019
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal bevacizumab in the management of choroidal neovascular membrane secondary to choroidal osteoma.
Narayanan R; Shah VA
Eur J Ophthalmol; 2008; 18(3):466-8. PubMed ID: 18465736
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal bevacizumab therapy on an as-per-needed basis in subfoveal choroidal neovascularization secondary to pathological myopia: 2-year outcomes of a prospective case series.
Iacono P; Parodi MB; Papayannis A; Kontadakis S; Sheth S; Bandello F
Retina; 2011 Oct; 31(9):1841-7. PubMed ID: 21775926
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.
Goff MJ; Johnson RN; McDonald HR; Ai E; Jumper JM; Fu A
Retina; 2007; 27(4):432-8. PubMed ID: 17420694
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of three intravitreal injections of bevacizumab in the treatment of exudative age-related macular degeneration].
Bidot ML; Malvitte L; Bidot S; Bron A; Creuzot-Garcher C
J Fr Ophtalmol; 2011 Jun; 34(6):376-81. PubMed ID: 21550687
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal bevacizumab for choroidal neovascularization secondary to choroidal osteoma.
Song WK; Koh HJ; Kwon OW; Byeon SH; Lee SC
Acta Ophthalmol; 2009 Feb; 87(1):100-1. PubMed ID: 19178391
[No Abstract] [Full Text] [Related]
12. Photodynamic therapy combined with intravitreal bevacizumab in a patient with choroidal neovascularization secondary to choroidal osteoma.
Jang JH; Kim KH; Lee SJ; Park JM
Korean J Ophthalmol; 2012 Dec; 26(6):478-80. PubMed ID: 23204807
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy of low-fluence photodynamic therapy and intravitreal ranibizumab for choroidal neovascular membrane in choroidal osteoma.
Morris RJ; Prabhu VV; Shah PK; Narendran V
Indian J Ophthalmol; 2011; 59(5):394-6. PubMed ID: 21836351
[TBL] [Abstract][Full Text] [Related]
14. Optical Coherence Tomography Angiography for Detecting Choroidal Neovascularization Secondary to Choroidal Osteoma.
Szelog JT; Bonini Filho MA; Lally DR; de Carlo TE; Duker JS
Ophthalmic Surg Lasers Imaging Retina; 2016 Jan; 47(1):69-72. PubMed ID: 26731212
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal bevacizumab for extrafoveal choroidal neovascularization after ocular trauma.
De Benedetto U; Battaglia Parodi M; Knutsson KA; Librando A; Bandello F; Lanzetta P; Iacono P
J Ocul Pharmacol Ther; 2012 Oct; 28(5):550-2. PubMed ID: 22554238
[TBL] [Abstract][Full Text] [Related]
16. Rescue therapy with intravitreal aflibercept for choroidal neovascularization secondary to choroidal osteoma non-responder to intravitreal bevacizumab and ranibizumab.
Saitta A; Nicolai M; Neri P; Reibaldi M; Giovannini A; Mariotti C
Int Ophthalmol; 2015 Jun; 35(3):441-4. PubMed ID: 25761547
[TBL] [Abstract][Full Text] [Related]
17. Choroidal Osteoma with Choroidal Neovascular Membrane treated with Anti- vascular Endothelial Growth Factor: A Rare Case with Review of Literatures.
Dorji P; Lepcha NT; Thapa R
Nepal J Ophthalmol; 2021 Jul; 13(24):196-201. PubMed ID: 35996784
[TBL] [Abstract][Full Text] [Related]
18. Bilateral choroidal osteoma with choroidal neovascular membrane treated with bevacizumab in a child.
Agarwal M; Kantha M; Mayor R; Venkatesh R; Shroff CM
Middle East Afr J Ophthalmol; 2014; 21(3):265-7. PubMed ID: 25100914
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal bevacizumab for the treatment of choroidal neovascularization secondary to angioid streaks: one year of follow-up.
El Matri L; Kort F; Bouraoui R; Karim B; Chebil A; Chaker N
Acta Ophthalmol; 2011 Nov; 89(7):641-6. PubMed ID: 21155980
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal bevacizumab monotherapy for choroidal neovascularisation secondary to choroidal osteoma.
Papastefanou VP; Pefkianaki M; Al Harby L; Arora AK; Cohen VM; Andrews RM; Sagoo MS
Eye (Lond); 2016 Jun; 30(6):843-9. PubMed ID: 27034203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
